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Background-—The risk of aortic complications associated with pregnancy in women with Marfan syndrome (MFS) is not fully
understood.
Methods and Results-—MFS women participating in the large National Registry of Genetically Triggered Thoracic Aortic Aneurysms
and Cardiovascular Conditions (GenTAC) were evaluated. Among 184 women with MFS in whom pregnancy information was
available, 94 (51%) had a total of 227 pregnancies. Among the women with pregnancies, 10 (10.6%) experienced a pregnancy-
related aortic complication (4 type A and 3 type B dissections, 1 coronary artery dissection, and 2 with significant [≥3 mm] aortic
growth). Five of 7 aortic dissections, including all 3 type B, and the coronary dissection (75% of all dissections) occurred in the
postpartum period. Only 5 of 8 women with pregnancy-associated dissection were aware of their MFS diagnosis. The rate of aortic
dissection was higher during the pregnancy and postpartum period (5.4 per 100 person-years vs 0.6 per 100 person-years of
nonpregnancy; rate ratio, 8.4 [95% CI=3.9, 18.4]; P<0.0001).
Conclusions-—Pregnancy in MFS is associated with an increased risk of aortic dissection, both types A and B, particularly in the
immediate postpartum period. Lack of knowledge of underlying MFS diagnosis before aortic dissection is a major contributing
factor. These findings underscore the need for early diagnosis, prepregnancy risk counseling, and multidisciplinary peripartum
management. ( J Am Heart Assoc. 2016;5:e004052 doi: 10.1161/JAHA.116.004052)
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E stimates of the risk of cardiovascular complications,primarily aortic dissection, associated with pregnancy in
women with Marfan syndrome (MFS) have varied widely.
Complication rates may be systematically overstated because
of publication bias, ascertainment bias, case reports or small
sample size, and inclusion of women whose aortic dissection
precedes and results in the diagnosis of MFS. Women who are
aware of their underlying diagnosis may receive prepregnancy
counseling, choose to forego pregnancy, have careful mon-
itoring and take beta-blockers during pregnancy, or undergo
prophylactic aortic surgery in anticipation of pregnancy, if
indicated.
In addition, few serial imaging data to permit correlation of
aortic diameters with risk of progressive dilatation and/or
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dissection associated with pregnancy are available. As a
consequence, recommendations regarding aortic root dimen-
sions above which pregnancy is discouraged vary1–5 and are
based on limited historical imaging data.1,2 Furthermore,
reported event rates may be confounded by prepregnancy
counseling.
The National Heart, Lung and Blood Institute–sponsored
National Registry of Genetically Triggered Thoracic Aortic
Aneurysms and Cardiovascular Conditions (GenTAC) offers an
opportunity to address some of these limitations by providing
comprehensive information on a large population of well-
characterized patients with MFS.
Methods
Study Population
The rationale and design of the GenTAC have been previously
described.6 In brief, GenTAC was established as a longitudinal
observational cohort study of individuals with genetically
triggered thoracic aortic aneurysm. Between 2006 and 2014,
3700 participants were enrolled in the original 6 centers
(Johns Hopkins University, Baylor College of Medicine, Oregon
Health & Sciences University, University of Pennsylvania,
University of Texas Health Science Center at Houston, and
Weill Cornell Medical College) and the 2 additional centers
(National Institute of Aging–Harbor Hospital and Queen’s
Medical Center) added in the second phase.7 Standardized
data collection included clinical information, patient question-
naire, imaging studies, and details of surgical interventions.
A core phenotyping laboratory provided validation of eligibility
diagnoses. Institutional review board approval was obtained
for this study at each of the 8 participating GenTAC regional
clinical centers. Individual informed consent was obtained
from each GenTAC Registry patient.
At the conclusion of registry enrollment (December 31,
2013), 893 patients with Marfan syndrome had been enrolled
in the GenTAC database, of whom 298 were women over the
age of 17 years. Of these, 184 (62%), who completed and
returned the Enrollment Patient Questionnaire and included
information on presence or absence of pregnancy, form the
basis for the current analyses. Requested information for each
pregnancy included age at pregnancy, outcome of pregnancy,
and complications during and after pregnancy, including aortic
dissection and aortic growth.
Based on questionnaire responses, as well as data on pre-
enrollment occurrence of aortic dissection or prophylactic
aortic surgery provided by the clinical centers, more-detailed
information was requested regarding all women with aortic
complications. Aortic complications were defined as aortic
dissection, excessive aortic growth (≥3 mm) during preg-
nancy, and need for prophylactic proximal aortic surgery
because of large or rapidly expanding aneurysm. Because
virtually all pregnancies preceded enrollment in the GenTAC
registry, imaging data regarding peripartum aortic diameters
were not systematically available. In those women who
indicated significant aortic growth had occurred during
pregnancy in the patient questionnaire, supporting data were
retrospectively requested from the clinical center. Data
regarding medication use during pregnancy, method of
delivery, and breastfeeding were not available.
Statistical Analysis
Demographic and phenotypic characteristics of never-preg-
nant and ever-pregnant women with MFS were compared
using an independent-samples t test for continuous variables
and Fisher’s exact test for categorical variables. In order to
determine age-adjusted rates of aortic surgery and dissection,
the period of exposure to need for prophylactic aortic surgery
and acute aortic dissection was calculated by subtracting 15
(presumed age at which pregnancy and associated dissection
risk might begin) from the age of enrollment in GenTAC (to
determine the number of years of risk before enrollment) and
multiplying by the number of women in the given group.
Pregnancy exposure was considered to occupy 1 year,
including the 3-month postpartum period. Ninety-five percent
confidence intervals were generated using the log of the rate
ratio and the standard error of its log and then calculating the
exponential. Rate ratios were compared using a generalized




Among 184 women in whom pregnancy information was
available, 94 (51%) reported a total of 227 pregnancies (mean,
2.5; median, 2.0; range, 1–6). Average maternal age was 29
and ranged from 13 to 43 years (2 women who had
pregnancies before the age of 18 are included in the
analysis). Pregnancy outcomes included 147 live births (2
sets of twins), 3 still births, 30 miscarriages, 38 abortions, 3
ectopic pregnancies, and 3 ongoing pregnancies; 3 did not
respond to the outcome question on the survey. Pregnancy
was complicated by hypertension in 19, diabetes mellitus in 1,
and premature rupture of membranes in 6. Women who
completed the patient questionnaire were older at the time of
enrolment (42 vs 36 years; P=0.002) and more likely to have
had type B aortic dissection and prophylactic surgery than
those who did not complete the questionnaire; however, the
latter differences were eliminated when adjusted for differ-
ences in age.
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Comparison of Never-Pregnant and Ever-Pregnant
Women
Demographic and phenotypic features of ever-pregnant and
never-pregnant MFS women are compared in Table 1. Women
who never became pregnant were significantly younger at age
of MFS diagnosis and at enrollment into GenTAC. Although
heights were similar, never-pregnant women weighed signif-
icantly less. Average systemic score was higher in never-
pregnant women. Phenotypic features that differed between
the 2 groups included a significantly higher proportion with
arachnodactyly, both wrist and thumb signs, and pes planus in
never-pregnant women. In addition, never-pregnant women
tended to have a higher proportion with thoracic skeletal
abnormalities, such as pectus carinatum and kyphosis.
At the time of GenTAC enrollment, ever-pregnant women
were more likely to have had a previous aortic dissection (25 of
94 [27%] vs 13 of 90 [14%]; P=0.047) and more likely to have
undergone prophylactic proximal aortic surgery (13 of 94 [14%]
vs 4 of 90 [4%]; P=0.04). Prophylactic proximal surgery in ever-
pregnant woman followed, rather than preceded, pregnancy in
all instances. Ever-pregnant women who had an aortic dissec-
tion were less likely than never-pregnant women to be aware of
their Marfan diagnosis before their dissection (8 of 25 [32%] vs
10 of 13 [77%]; P=0.016). Among the women who had not
undergone proximal aortic surgery at time of registry entry and
in whom imaging data were available (n=53), there were no
differences in aortic root dimensions (3.90.47 vs
4.00.56 cm; P=0.44) or aortic root Z scores (3.41.75 vs
3.42.27; P=0.92) in never-pregnant versus ever-pregnant
women, respectively, including following adjustment for differ-
ences in age between the 2 groups.
Aortic Complications Associated With Pregnancy
Among the 94 women with at least 1 pregnancy, 10 (10.6%)
developed an aortic complication in the peripartum period
(defined as pregnancy and 3 months postpartum), including 4
type A dissections, 3 type B dissections, 2 with significant
(≥3 mm) aortic growth, and 1 coronary artery dissection.
Details of these complications are presented in Table 2. Of
note, all 3 type B dissections, 2 of the type A dissections, and
the coronary artery dissection (overall, 75% of dissections)
occurred in the postpartum period.
Knowledge of MFS Diagnosis Before Pregnancy
and Before Aortic Dissection
Among the 94 ever-pregnant women, only 42% were aware of
their diagnosis before their first pregnancy. Five of the 8women
who experienced pregnancy-related aortic or coronary dissec-
tions were aware of their diagnosis before the event. Aortic
dissections not related to pregnancy occurred in 17 of the 84
ever-pregnant women, 8 of whomwere aware of their diagnosis
before the occurrence of the aortic dissection. Among the 90
never-pregnantwomen inwhom13 aortic dissections occurred,
10 were aware of their diagnosis before the dissection
occurred. Thus, 12 of 30 (40%) non-pregnancy-related dissec-
tions occurred in women who were unaware of their diagnosis,
whereas 60% occurred after the diagnosis.
Comparison of Ever-Pregnant Women With and
Without Aortic Complications
Demographic and phenotypic features of pregnant women
who did not have aortic complications are compared to those
who did have complications in Table 3. There were no
Table 1. Comparison of Demographic and Phenotypic





Age at diagnosis, y 1311 2717 <0.0001













Arm span, cm 17624 17528 0.97
Lower segment, cm 9116 9114 0.81
Pectus carinatum, % 34 24 0.08
Pectus excavatum, % 26 24 0.62
Scoliosis, % 62 59 0.44
Kyphosis, % 24 15 0.10







Striae atrophicae, % 57 48 0.23
Wrist sign, % 61 44 0.0047
Thumb sign, % 65 46 0.0015
Ectopia lentis, % 47 43 0.46
Myopia >4 diopters, % 31 22 0.18
Mitral prolapse, %* 65 63 0.52
Systemic score 6.52.8 5.23.2 0.0025
DBP indicates diastolic blood pressure; SBP, systolic blood pressure.
*Ascertained from standardized clinical evaluation form.
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significant differences between the 2 groups. In addition, the
mean number of pregnancies did not differ between those
without and with aortic complications (2.5 vs 2.4; P=0.82).
Use of beta-blocking agents was more common at the time of
enrollment in those with complications (50% vs 13%;
P=0.012).
Impact of Pregnancy on Rates of Aortic
Dissection and Prophylactic Surgery
The rate of prophylactic proximal aortic surgery among ever-
pregnant women was 0.43 per 100 patient years (95%
CI=0.198, 0.668) and 0.20 per 100 patient-years (95%
CI=0.004, 0.405) among never-pregnant women (rate
ratio=2.12 [95% CI=0.690–6.494]; P=NS). Aortic dissection
rates associated with pregnancy and the postpartum period
were significantly higher than nonpregnancy dissection rates
(5.4 per 100 person-years [95% CI, 1.7, 9.2] vs 0.6 per
100 patient-years [95% CI=0.42–0.87]; rate ratio=8.4 [95%
CI=3.9–18.4]; P<0.0001).
Discussion
The GenTAC Registry represents the largest analysis to date
of pregnancy risk in women with MFS. Our results underscore
the risk of the peripartum period for aortic dissection. The
rates of aortic dissections unrelated and related to pregnancy
(0.6 and 5.4 per 100 patient-years) noted in the GenTAC
Registry far exceed recently published population-based rates
of aortic dissection among women (0.0024 per 100 patient-
years in Oxfordshire, UK,8 and 0.0029 per 100 patient-years
in Emilia-Romagna, Italy9). The lack of knowledge of under-
lying MFS diagnosis in almost 50% of registry women with
aortic dissection related to pregnancy is a common finding in
the existing literature and underscores the need for early
diagnosis, prepregnancy risk counseling, and multidisciplinary
peripartum management.5,10
The early literature on pregnancy risk in women with MFS
is limited to publication of single case reports11–14 or very
small series.15–17 In addition, the diagnosis of MFS was not
always firmly established, but presumptive, based on non-
specific skeletal features12,16,17 or in the setting of underlying
bicuspid aortic valve,15 a known risk factor for aortic
aneurysm and dissection. Furthermore, some women with a
firm diagnosis of MFS at the time might have actually had
Loeys-Dietz syndrome, which had not yet been described and
may carry a higher risk of dissection than MFS. In contrast,
MFS diagnosis in the present study was based on systematic
application of revised Ghent criteria18 with central review by
the GenTAC Phenotyping Core.
The first large series, published in 1981 with the goal of
providing a more-representative assessment of pregnancy








1 36 Type A dissection Peripartum Beta-blocker Yes Dissection discovered after delivery with
subsequent surgery
2 35 Type A dissection Third trimester No No Emergency Caesarian section followed by
aortic surgery
3 34 Type A dissection 6 days
postpartum
No No Emergency aortic surgery




Yes Emergency aortic surgery
5 36 Type B dissection 6 weeks
postpartum
Beta-blocker Yes Elective surgery for expanding aneurysm
6 29 Type B dissection 3 days
postpartum
Unknown Yes Emergency aortic surgery
7 27 Type B dissection 1 day
postpartum
No No Elective surgery 5 years later




No Yes Emergency coronary bypass surgery
9 28 Aortic growth (3.6–4.0 cm) Pregnancy None Yes Subsequent surgery for type A dissection
10 34 Aortic growth (4.7–5.3 cm) Pregnancy Beta-blocker Yes Caesarian section; aortic surgery 6 months
postpartum
BP indicates blood pressure.
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risk, included 105 pregnancies in 26 women with MFS seen at
the Johns Hopkins Medical Genetics Clinic.1 Twelve of these
26 women had evidence of cardiovascular disease (heart
murmurs in 6, mitral prolapse in 2, “some degree of aortic
dilatation” in 3, and palpitations in 1). Three of the 12 women
had cardiovascular complications (transient murmur, progres-
sive heart failure attributed to severe mitral regurgitation, or
atrial tachycardia); there were no aortic complications. The
number of women having echocardiograms was not provided,
but none were reported to have aortic root diameters over
42 mm. Based on these data, Pyeritz recommended against
pregnancy in women with aortic diameters over 40 mm.1
A subsequent prospective study of 45 pregnancies in 21
women with MFS evaluated at Johns Hopkins between 1983
and 1992 noted aortic dissections in 3 women,19 1 type B
dissection at 20 weeks’ gestation (previously published as a
case report by Mor-Yosef et al16), a type A dissection
misconstrued as rapid aortic expansion until elective surgery
postpartum, and distal extension of a previous type A
dissection operated upon before pregnancy and occurring
postpartum in the setting of intravenous drug use. Impor-
tantly, echocardiographic surveillance was performed in 22 of
28 pregnancies carried through the third trimester with “little
or no change in aortic root diameter during pregnancy.”
More-recent studies have provided somewhat more-
comprehensive peripartum imaging data to permit better
assessment of risk of aortic complications. In a Dutch study of
127 women with MFS evaluated between 1993 and 2004, 61
had been pregnant, of whom 23 women with 33 pregnancies
had aortic dimensions determined by echocardiography (only
10 before and after pregnancy).4 Only 1 woman, with a
previous type A dissection, developed a type B dissection
during her second pregnancy. Nine of the other 22 women
had aortic root diameters ≥40 mm (range, 40–45) with
insignificant pregnancy-associated diameter change. Based
on these data, the investigators suggested that pregnancy in
the absence of pre-existing aortic dissection is safe up to
45 mm.
The most comprehensive study to date including imaging
data involved 69 women with a total of 199 pregnancies
evaluated in Salt Lake City5; 32 of these women were aware
of their MFS diagnosis, had not had previous aortic surgery,
and were followed prospectively for a total of 52 pregnancies.
In 14 pregnancies (27%), aortic root diameter was ≥40 mm.
Although there were no aortic peripartum complications,
women who had been pregnant were more likely to receive
prophylactic aortic surgery than the 29 never-pregnant
women (13.0% vs 6.5%; P=0.03), similar to findings in the
current study. However, because women in our study who had
had pregnancies were older than those who had never been
pregnant, there was no significant difference between the 2
groups in annual rate of proximal aortic surgery. None of the
69 women with pregnancies in the Salt Lake City study
experienced a peripartum dissection, and none of the
nulliparous women experienced aortic dissection. Lower rates
of aortic dissection in these women, compared to GenTAC
women, may be attributed to older age in the latter cohort and
hence longer duration of exposure.
Lack of knowledge of the underlying diagnosis of MFS was
common in pregnancy-associated aortic dissection in the
GenTAC Registry as well as in earlier reports. In an English
registry including 36 women with MFS, 6 women had
pregnancy-related complications.20 Three of 4 women with
acute dissections and both women with rapid aortic expan-
sion necessitating postpartum surgery were unaware of their
MFS diagnosis before their pregnancies. In a letter survey
sent to members of the Dutch Marfan Association, 5 aortic
dissections occurred in 44 women, only 3 of whom were
aware of their diagnosis.21 In a retrospective analysis of a
Table 3. Comparison of Demographic and Phenotypic










Age at diagnosis, y 2716 2211 0.31
Age at enrollment, y 4714 4213 0.26


















Arm span, cm 17525 17924 0.76
Lower segment, cm 9115 9216 0.98
Pectus carinatum, % 34 24 1.0
Pectus excavatum, % 23 50 0.12
Scoliosis, % 62 70 0.74
Wrist sign, % 48 40 0.75
Thumb sign, % 49 50 1.0
Ectopia lentis, % 46 40 0.75
Mitral prolapse, %† 75 70 0.29
DBP indicates diastolic blood pressure; SBP, systolic blood pressure.
*Coronary artery dissection patient is included in this group.
†
Ascertained from standardized clinical evaluation form.
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French outpatient MFS clinic, 7 of 85 women suffered a
peripartum aortic complication, only 3 of whom were aware of
their diagnosis.22 The same group followed 18 women
prospectively using standardized guidelines, including serial
echocardiography, beta-blockade therapy, and tailored deliv-
ery approaches.10 The sole aortic dissection occurred in a
woman referred at 35 weeks of pregnancy with an aortic
diameter of 47 mm who had an acute type A dissection at
37 weeks just before a planned cesarean delivery. In the
current study, the significantly earlier age at diagnosis of MFS
in the never-pregnant group (1311 vs 2717 years) may
have influenced recommendations and decisions regarding
reproduction.
MFS is classically associated with proximal aortic dilatation;
accordingly, type A dissections are much more common than
dissections exclusively involving the distal aorta. Among 100
MFS patients with aortic dissection, 80% involved the ascend-
ing aorta whereas 20% were isolated to the descending aorta.23
Strikingly similar results were reported in a Swiss population,
wherein initial aortic dissection was type A in 77% and type B in
23%.24 Thus, it is noteworthy that 3 of the 7 aortic dissections in
our series were type B dissections, all of which occurred in the
postpartum period and none of which were associated with
previous proximal aortic surgery. Although cardiac output is
increased during pregnancy because of increases in stroke
volume and heart rate, substantial further increases occur in
association with labor and delivery, potentially further increas-
ing pulsatile stress on the aorta. Type B dissections have been
described in previous reports4,13–16,21,22; of these, 5 of 8 were
postpartum. Reports of postpartum type A dissection are less
common,21,25 including 1 of 3 in our series.
Study Limitations
There are several potential limitations to the current study.
Although aortic dissection is unlikely to go unrecognized and
miscategorized, the prevalence of significant aortic growth
may be underestimated because of reliance on the patient
questionnaire. However, all such instances reported on the
patient questionnaire were further explored through clarifi-
cation by site investigators. In addition, we did not collect
systematic peripartum imaging data because the pregnancies
predated participation in the registry (average age of
pregnancy 29 years vs average age at enrollment of
47 years). The lack of systematic peripartum imaging data
in the GenTAC cohort precludes assessment of pregnancy
risk based on aortic dimensions. Another limitation includes
the lack of systematic information about peripartum medi-
cation use and lactation given the retrospective ascertain-
ment of pregnancy data. Although the sites involved in
GenTAC were, of necessity, referral centers for patients with
genetically mediated thoracic aortic aneurysms, each site
made every effort to recruit all eligible patients, as evidenced
by the large number of total enrollees. Unfortunately,
GenTAC did not include funding for genotyping; however,
any participants whose clinical genetic testing identified
mutations in genes other than fibrillin 1 would have had their
diagnosis changed from MFS to the appropriate alternative
diagnosis. Furthermore, the GenTAC Phenotyping Core
Laboratory at Johns Hopkins University provided standard-
ization and validation of diagnoses. Fibrillin-1 mutations were
documented in 16 ever-pregnant and 11 never-pregnant
women in the present study.
Conclusions
Pregnancy in women with MFS is associated with an 8-fold
increase in risk of aortic dissection, both types A and B,
particularly in the postpartum period. The current data
support a recommendation for general cardiac checkup with
echocardiographic assessments of the aortic root and
ascending aorta before planned pregnancy or during
unplanned pregnancy. Our findings also suggest that peripar-
tum ultrasound imaging should additionally include the
descending thoracic aorta, although evidence that aneurysmal
dilatation precedes type B dissection is lacking. Lack of
knowledge of underlying MFS contributes to the risk of aortic
complications during pregnancy. These findings underscore
the need for early diagnosis, prepregnancy risk counseling,
and multidisciplinary periartum management.
Appendix
GenTAC Investigators
Johns Hopkins University: Williams Ravekes, MD, Harry C.
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Song, MD, PhD, G. Michael Silberbach, MD. University of
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MD, Karianna Milewski, MD, PhD. Weill Cornell Medical
College: Richard B. Devereux, MD, Mary J. Roman, MD,
Jonathan W. Weinsaft, MD. The Queen’s Medical Center: Ralph
Shohet, MD. National Institute on Aging: Nazli McDonnell,
MD. MedStar Health Research Institute: Federico M. Asch,
MD. University of Michigan: Kim A. Eagle, MD. National Heart,
Lung, and Blood Institute: H. Eser Tolunay, PhD, Patrice
Desvigne-Nickens, MD. National Institute of Arthritis, Muscu-
loskeletal and Skin Diseases: Hung Tseng, PhD. RTI Interna-
tional: Barbara L. Kroner, PhD.
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